Windtree Therapeutics (WINT) announced it has entered into a Common Stock Purchase Agreement for up to $500M to establish an equity line of credit, ELOC, and bolster its BNB cryptocurrency treasury strategy. The company also entered into an additional $20 million stock purchase agreement with Build and Build Corp. Ninety-nine percent of the proceeds from the ELOC and Build and Build Corp will be allocated to acquiring BNB cryptocurrency. “We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy,” stated Jed Latkin, CEO of Windtree. “Pending stockholder approval, the opportunity to secure additional funds for purchasing more BNB cryptocurrency is essential to our strategy.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree Therapeutics, Kraken announce strategic partnership
- Windtree Therapeutics Announces $60M Securities Agreement
- Windtree Therapeutics to launch BNB crypto treasury strategy
- Windtree Therapeutics Issues Convertible Promissory Notes
- Windtree Therapeutics announces issuance of istaroxime patent for U.S.